Top Markets
Coin of the day
BioHarvest Sciences Inc. Common Stock BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. Common Stock

BHST
Rang in Aktien #27027
BioHarvest Sciences Inc. functions as a biotechnology firm with operations... BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells. The company harnesses this advanced technology to craft evidence-based and clinically validated therapeutic products for both its nutraceutical and pharmaceutical offerings. Beyond its own development, it also provides contract development and manufacturing services. Its product portfolio includes various wellness items, notably VINIA, a dietary supplement derived from red grape cells, which delivers the full spectrum of polyphenols naturally present in red grapes. The company conducts business in Israel and the United States, with its corporate base in Vancouver, Canada.
Aktienkurs
$2.06
Zuletzt synchronisiert: 2026-08-19
Marktkapitalisierung
$35.61M
Veränderung (1 Tag)
-2.61%
Veränderung (1 Jahr)
-77.76%
Land
CA
Handel BioHarvest Sciences Inc. Common Stock (BHST)
EPS für BioHarvest Sciences Inc. Common Stock (BHST)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von BioHarvest Sciences Inc. Common Stock beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von BioHarvest Sciences Inc. Common Stock von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber